Adverse events of raltegravir and dolutegravir

Elzi, L; Erb, S; Furrer, H; Cavassini, M; Calmy, A; Vernazza, P; Gunthard, H; Bernasconi, E; Battegay, M

Battegay, M (reprint author), Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland.

AIDS, 2017; 31 (13): 1853

Abstract

Objective: To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. Design: Pros......

Full Text Link